Life Sciences Partners
Investor profile
Investment firm
Deals
13
distinct rounds
Companies
9
backed
Active span
2006–2019
14 yrs
Total round €
€298M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Merus | Netherlands | 3 | €126M |
| DNA Script | France | 1 | €33M |
| Xeltis | Switzerland | 1 | €31M |
| Sequana Medical | Switzerland | 2 | €30M |
| Atlantic Therapeutics | Ireland | 1 | €28M |
| Vivasure Medical | Ireland | 1 | €16M |
| Kuros Biosurgery | Switzerland | 1 | €14M |
| Nexstim | Finland | 1 | €11M |
| Mint Solutions | Netherlands | 2 | €9.4M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Merus | Series C | €73M | 2015-07 |
| DNA Script | Series B | €33M | 2019-03 |
| Merus | Series B | €31M | 2013-09 |
| Xeltis | Series B | €31M | 2014-11 |
| Atlantic Therapeutics | Series B | €28M | 2018-12 |
| Merus | Series A | €22M | 2006-12 |
| Sequana Medical | Series C | €21M | 2014-03 |
| Vivasure Medical | Series C | €16M | 2016-08 |
| Kuros Biosurgery | Growth/Late | €14M | 2015-07 |
| Nexstim | Other | €11M | 2010-12 |